Opioid Zehirlenmeleri

Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013 Jun 01;87(11):766-72.

Özden, SY. (2004). Uyuşturucu Madde Bağımlılığı. İstanbul: Nobel Tıp Kitapevleri.

Lalic S, Jokanovic N, Ilomäki J, Gisev N, Lloyd B, Lubman DI, Bell JS. Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review. Res Social Adm Pharm. 2019 Aug;15(8):925- 935.

Rzasa Lynn R, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018 Jan;9(1):63-88.

Sadock, B. J., Kaplan, H. I., & Sadock, V. A. (2007). Kaplan & Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry (10th ed.). Philadelphia: Wolter Kluwer/Lippincott Williams & Wilkins.

LaForge KS, Yuferov V, Kreek MJ. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur J Pharmacol. 2000 Dec 27;410(2-3):249-268.

Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005 Mar;57(1):1-26.

Tejada M. A., Montilla-García A., Sánchez-Fernández C., Entrena J. M., Perazzoli G., Baeyens J. M., et al. (2014).Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors.Psychopharmacology (Berl)231(19), 3855–3869. 10.1007/s00213-014-3524-3

MacKenzie M, Zed PJ, Ensom MHH. Opioid pharmacokineticspharmacodynamics: clinical implications in acute pain Management in Trauma. Annals of pharmacology. 2016;50(3):209–18.

Dean L, Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W. Codeine Therapy and CYP2D6 Genotype. March 16, 2017.

Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesth Analg. 2017 Jan. 124 (1):44-51.

Owusu Obeng A., Hamadeh I., Smith M. Review of Opioid Pharmacogenetics and Considerations for Pain Management. Pharmacother. J. Hum. Pharmacol. Drug Ther. 2017;37:1105–1121. doi: 10.1002/phar.1986

Fareed A, Stout S, Casarella J, et al. Illicit opioid intoxication: diagnosis and treatment. Subst Abus. 2011;5:17–25.

Byard RW, Gilbert JD. Narcotic administration and stenosing lesions of the upper airway a potentially lethal combination. J Clin Forensic Med. 2005 Feb. 12(1):29-31

Boyer EW (2012) Management of opioid analgesic overdose. N Engl J Med 367: 146-55.

Journal of Medicine. Massachussetts Medical Society; 2012. p. 146–55.

Everett Stephens, MD; Chief Editor: Jeter (Jay) Pritchard Taylor, III, MD, Opioid Toxicity Updated: Jun 06, 2020, emedicine.medscape.com

Rıtter JM, Lewis LD, Mant T, Ferro A (2008) Drugs and Alcohol Abuse. A Text Book of Clinical Pharmacology and Theropeutics. Fifth edition. London, s. 433-443.

Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 8th Edition. McGraw-Hill Education / Medical; 2016.

Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009 Dec. 104(12):2067-74.

Narcan Nasal Spray (naloxone ntranasal) [package nsert]. Radnor, PA: Adapt Pharma, Inc. November, 2015.

FDA News Release. FDA moves quckly to approve easy-to-use nasal spray to treat opod overdose. U.S. Food and Drug Admnstraton. Avalable at https://wayback.archve- t.org/7993/20180125101447/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm. 2015 Nov 18; Accessed: June 6, 2020.

Guideline, Thanacoody R, Caravati EM, Troutman B, Hojer J, Benson B, Hoppu K, et al. Position paper update: Whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol (Phila). 2015 Jan. 53(1):5-12.

Opioid Overdose: Data Overview. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/drugoverdose/data/index.html. March 19, 2020; Accessed: June 6, 2020.

Porter R, O'Reilly H. Pulmonary hemorrhage: a rare complication of opioid overdose. Pediatr Emerg Care. 2011 Aug. 27(8):742-4.

Asher J. Schranz, MD, Aaron Fleischauer, PhD, [...], and David L. Rosen, MD, PhD, Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017

Fine PG. Principles of effective pain management at the End of Life. [CME] 2006 [cited 2006 November]; Available from: http://www.medscape.com/viewprogram/6079

Christenson J, Etherington J, Grafstein E, et al: Early discharge of patients with presumed opioid overdose: development of a clinical prediction rule. Acad Emerg Med 7: 1110, 2000.

Willman MW, Liss DB, Schwarz ES, Mullins ME: Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol (Phila) 55: 81, 2017.

Clemency BM,Eggleston W,Shaw EW,et al. Hospital observation upon reversal (HOUR) with naloxone: a prospective clinical prediction rule validation study.Acad Emerg Med 2018 Dec 28